PLx Pharma Inc reports results for the quarter ended in March - Earnings Summary

PLx Pharma Winddown

14/05/2021 18:54

* PLx Pharma Inc  PLXP.OQ  reported a quarterly adjusted loss
of 73 cents​​ per share for the quarter ended in March. The mean
expectation of three analysts for the quarter was for a loss
of 21 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* PLx Pharma Inc's reported EPS for the quarter was a loss of 73
cents​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* PLx Pharma Inc shares had risen by 8.5% this quarter and
gained 77.5% so far this year.
* The company reported a quarterly loss of $11.86 million.
* Wall Street's median 12-month price target for PLx Pharma Inc
is $16.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 14 at 05:54 p.m. GMT.
​All figures in US dollars